Back to the full story3 sources · FDA approves new blood test for Alzheimer’s disease◆ Analytics
FDA approves new blood test for Alzheimer’s disease
Deterministic text analytics computed across all 3 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
testalzheimerbloodapprovaldiseaserocheclearancegrantedelecsysfourth
Top phrases
blood testalzheimer diseaseroche eli lilly alzheimer bloodlilly alzheimer blood test getseli lilly alzheimer blood testtest for alzheimer diseaselilly alzheimer blood testroche eli lilly alzheimereli lilly alzheimer bloodalzheimer blood test gets
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
- Roche · 3 sources
- FDA · 2 sources
Unique to one source
- Alzheimer’s · The Hill
- The Food · The Hill
- Drug Administration · The Hill
- Eli Lilly's Alzheimer's · Reuters
- Eli Lilly’s Alzheimer’s · The Straits Times
- US FDA · The Straits Times
- European · The Straits Times
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer's disease, marking the fourth time such a blood test has been approved in less than two years." · The Hill
- "Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease." · The Hill
- "The nod follows European approval for the Elecsys pTau217 test in May." · The Straits Times